|
Name |
Phomoparagin A
|
| Molecular Formula | C29H37NO3 | |
| IUPAC Name* |
4-benzyl-2-hydroxy-5,6,14,16-tetramethyl-7-methylidene-11-oxa-3-azapentacyclo[8.8.0.01,5.08,18.012,19]octadec-16-en-2-one
|
|
| SMILES |
C=C1C2OC3CC(C)CC(C)=CC4C3C2C2(C(=O)NC(Cc3ccccc3)C2(C)C1C)C4O
|
|
| InChI |
InChI=1S/C29H37NO3/c1-15-11-16(2)13-21-23-20(12-15)26(31)29-24(23)25(33-21)17(3)18(4)28(29,5)22(30-27(29)32)14-19-9-7-6-8-10-19/h6-10,12,16,18,20-26,31H,3,11,13-14H2,1-2,4-5H3,(H,30,32)/b15-12-/t16-,18-,20+,21-,22+,23-,24+,25-,26-,28+,29+/m1/s1
|
|
| InChIKey |
IGWABSJTWXINBH-FWILZWOQSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 447.62 | ALogp: | 4.3 |
| HBD: | 2 | HBA: | 3 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 58.6 | Aromatic Rings: | 6 |
| Heavy Atoms: | 33 | QED Weighted: | 0.638 |
| Caco-2 Permeability: | -4.837 | MDCK Permeability: | 0.00016661 |
| Pgp-inhibitor: | 0.089 | Pgp-substrate: | 0.003 |
| Human Intestinal Absorption (HIA): | 0.013 | 20% Bioavailability (F20%): | 0.011 |
| 30% Bioavailability (F30%): | 0.005 |
| Blood-Brain-Barrier Penetration (BBB): | 0.246 | Plasma Protein Binding (PPB): | 92.16% |
| Volume Distribution (VD): | 1.553 | Fu: | 3.91% |
| CYP1A2-inhibitor: | 0.022 | CYP1A2-substrate: | 0.307 |
| CYP2C19-inhibitor: | 0.453 | CYP2C19-substrate: | 0.827 |
| CYP2C9-inhibitor: | 0.231 | CYP2C9-substrate: | 0.159 |
| CYP2D6-inhibitor: | 0.017 | CYP2D6-substrate: | 0.339 |
| CYP3A4-inhibitor: | 0.711 | CYP3A4-substrate: | 0.721 |
| Clearance (CL): | 11.496 | Half-life (T1/2): | 0.007 |
| hERG Blockers: | 0.053 | Human Hepatotoxicity (H-HT): | 0.396 |
| Drug-inuced Liver Injury (DILI): | 0.038 | AMES Toxicity: | 0.043 |
| Rat Oral Acute Toxicity: | 0.993 | Maximum Recommended Daily Dose: | 0.885 |
| Skin Sensitization: | 0.138 | Carcinogencity: | 0.05 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.007 |
| Respiratory Toxicity: | 0.955 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003937 | ![]() |
0.564 | D0V3ZA | ![]() |
0.250 | ||
| ENC003956 | ![]() |
0.529 | D0SP3D | ![]() |
0.243 | ||
| ENC003936 | ![]() |
0.521 | D09NNH | ![]() |
0.243 | ||
| ENC005759 | ![]() |
0.516 | D01TSI | ![]() |
0.243 | ||
| ENC006060 | ![]() |
0.484 | D05VQI | ![]() |
0.235 | ||
| ENC005760 | ![]() |
0.472 | D06CWH | ![]() |
0.232 | ||
| ENC005127 | ![]() |
0.468 | D0W7RJ | ![]() |
0.231 | ||
| ENC005128 | ![]() |
0.460 | D0R1BD | ![]() |
0.230 | ||
| ENC004540 | ![]() |
0.437 | D0M6VK | ![]() |
0.227 | ||
| ENC004543 | ![]() |
0.415 | D0IN7I | ![]() |
0.226 | ||